Table 4. Comparison of secondary outcomes at post-intervention.
| Outcomes | MBCT-HeLM (N = 11) |
MBSR (N = 10) |
TAU (N = 7) |
MBCT-HeLM vs. MBSR | MBCT-HeLM vs. TAU | ||
|---|---|---|---|---|---|---|---|
| Mean (SD) | Mean (SD) | Mean (SD) | Mean diff. | 95 % CI | Mean diff. | 95 % CI | |
| Blood pressure | |||||||
| Systolic blood pressure (mmHg) | 130.4 (20.7) | 143.8 (20.7) | 129.8 (14.8) | -13.4 | -42.5 to 15.7 | 0.6 | -20.3 to 21.4 |
| Diastolic blood pressure (mmHg) | 73.2 (16.4) | 76.5 (17.8) | 73.5 (9.3) | -3.3 | -24.2 to 17.7 | -0.3 | -15.9 to 15.3 |
| GAD-7 | 4.8 (4.8) | 4.4 (2.8) | 6.4 (3.9) | 0.4 | -3.6 to 4.4 | -1.6 | -6.2 to 3.0 |
| CAQ* | 18.3 (14.3) | 18.0 (1.4) | 30.5 (13.6) | 0.3 | -16.5 to 17.2 | -12.1 | -33.1 to 8.8 |
| RAND 36-Item Health Survey 1.0 | |||||||
| RAND 36-Item Physical | 49.5 (15.3) | 56.4 (28.1) | 59.1 (32.7) | -6.9 | -27.6 to 13.9 | -9.6 | -40.2 to 21.2 |
| RAND 36-Item Psychological | 55 .5 (19.1) | 60.8 (14.6) | 48.7 (23.7) | -5.3 | -21.6 to 11.0 | 6.8 | -14.7 to 28.3 |
| FFMQ (Total) | 128.0 (18.0) | 124.0 (18.3) | 110.0 (6.7) | 4.0 | -15.6 to 23.4 | 18.0 | 2.1 to 33.3 |
| SCS (Total) | 2.6 (0.6) | 2.8 (0.8) | 2.4 (0.7) | -0.2 | -0.9 to 0.5 | 0.2 | -0.5 to 0.8 |
| PANAS-Positive | 25.3 (7.1) | 32.7 (4.3) | 28.2 (7.4) | -7.4 | -13.6 to -1.3 | -2.9 | -10.6 to 4.7 |
| PANAS-Negative | 18.7 (9.8) | 16.3 (6.6) | 19.4 (9.1) | 2.3 | -6.3 to 11.0 | -0.7 | -10.8 to 9.3 |
| IPQ-R | |||||||
| IPQ-R timeline acute/chronic | 18.1 (3.6) | 18.6 (2.8) | 18.7 (6.7) | -0.5 | -3.8 to 2.8 | -0.6 | -6.0 to 4.7 |
| IPQ-R timeline cyclical | 11.5 (4.0) | 11.1 (3.2) | 10.4 (4.4) | 0.4 | -3.4 to 4.3 | 1.1 | -3.5 to 5.7 |
| IPQ-R consequences | 19.7 (6.2) | 18.8 (5.3) | 19.0 (6.1) | 0.9 | -5.0 to 6.6 | 0.7 | -5.8 to 7.2 |
| IPQ-R personal control | 23.2 (3.7) | 19.2 (3.9) | 23.1 (4.8) | 4.0 | 0.1 to 7.8 | 0.1 | -4.4 to 4.5 |
| IPQ-R treatment control | 16.8 (2.2) | 13.8 (4.2) | 17.7 (2.4) | 3.0 | -0.4 to 6.5 | -0.9 | -3.4 to 1.7 |
| IPQ-R illness coherence | 20.3 (2.3) | 16.5 (5.9) | 18.8 (2.8) | 3.8 | -0.7 to 8.4 | 1.5 | -1.3 to 4.3 |
| IPQ-R emotional representations | 17.5 (5.2) | 19.3 (5.1) | 18.1 (4.6) | -1.8 | -7.2 to 3.6 | -0.6 | -6.0 to 4.8 |
| SAQ** | |||||||
| SAQ- physical limitations | 43.8(19.2) | 41.8(21.4) | 41.9(5.3) | 2.0 | -25.7 to 29.7 | 1.9 | -25.8 to 29.5 |
| SAQ- angina stability | 52.0(17.8) | 60.0(20.0) | 50.0(20.5) | -8.0 | -35.7 to 19.8 | 2.0 | -1.3 to 65.3 |
| SAQ- angina frequency | 68.1(13.3) | 68.3(13.6) | 45.8 (17.6) | -0.2 | -18.8 to 18.2 | 22.3 | -6.1 to 50.5 |
| SAQ- treatment satisfaction | 58.0 (18.5) | 64.7(11.4) | 65.0 (11.9) | -6.7 | -29.2 to 15.8 | -7.0 | -36.8 to 22.8 |
| SAQ- disease perception | 50.6 (23.4) | 58.6(12.8) | 44.4 (27.7) | -8.0 | -35.5 to 19.5 | 6.2 | -38.3 to 50.8 |
Note: TAU: Treatment As Usual; SD: Standard Deviation; CI: Confidence Intervals; GAD-7: Generalised Anxiety Questionnaire-7; CAQ: Cardiac Anxiety Questionnaire; FFMQ: Five Facet Mindfulness Questionnaire; SCS: Self-Compassion Scale; PANAS: Positive and Negative Affect Scale; IPQ-R: Illness Perception Questionnaire-Revised. SAQ: Seattle Angina Questionnaire;
*
CAQ was completed by participants with heart conditions only (MBCT, n=6; MBSR, n=5; TAU, n=3)
**
SAQ was completed by participants with heart conditions only (MBCT, n=6; MBSR, n=5; TAU, n=3).